i m not losing weight on tirzepatide Why Am Mounjaro? Not Losing Weight on Tirzepatide?

[3] [6] No other significant pharmacokinetic interactions affecting drug absorption, distribution, metabolism, or elimination have been identified between these agents

The most common side effect reported in clinical trials was joint pain, likely due to water retention [32]

Ulteriori dati (SURMOUNT-4, NEJM 2024) mostrano che la continuazione della terapia essenziale per mantenere i risultati: dopo interruzione, i pazienti hanno recuperato parte del peso

Rezende SB, Oshiro KGN, Jnior NGO, Franco OL, Cardoso MH (2021) Advances on chemically modified antimicrobial peptides for generating peptide antibiotics

Tirzepatide found in Mounjaro has both GLP-1 and GIP receptor agonist actions

Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, USA